Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study

We aimed to identify clinical predictors of long-term response to abiraterone (defined as >12 months drug exposure) in a retrospective cohort of metastatic castration-resistant prostate cancer patients treated in post-docetaxel setting at 24 Italian centers. The Cox proportional hazards model was...

Descripción completa

Detalles Bibliográficos
Autores principales: Verzoni, Elena, Giorgi, Ugo De, Derosa, Lisa, Caffo, Orazio, Boccardo, Francesco, Facchini, Gaetano, Porcu, Luca, Vincenzo, Fabio De, Zaniboni, Alberto, Chiuri, Vincenzo Emanuele, Fratino, Lucia, Santini, Daniele, Adamo, Vincenzo, Vivo, Rocco De, Dinota, Angelo, Messina, Caterina, Ricotta, Riccardo, Caserta, Claudia, Scavelli, Claudio, Susi, Marina, Tartarone, Alfredo, Surace, Giuseppe, Mosca, Alessandra, Bruno, Michele, Barni, Sandro, Grassi, Paolo, Procopio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129994/
https://www.ncbi.nlm.nih.gov/pubmed/27223078
http://dx.doi.org/10.18632/oncotarget.9485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129994/
https://www.ncbi.nlm.nih.gov/pubmed/27223078
http://dx.doi.org/10.18632/oncotarget.9485

Ejemplares similares